Posts by Sandra Ansanay-Alex
AC Immune Receives $4 million from The Vijay and Marie Goradia Charitable Foundation
AC Immune SA, a Swiss clinical-stage biopharmaceutical company pioneering precision therapeutics for neurodegenerative diseases, announced it will receive a research grant of $4 million from The Vijay and Marie Goradia Charitable Foundation. The grant will support extending Part 1 of the ongoing Phase 2 VacSYn trial of ACI-7104, AC Immune’s anti-alpha-synuclein (a-syn) active immunotherapy, in…
Read MorePrecise Health Gets a CHF 900’000 Innosuisse Grant
The Valais-based startup and EPFL spin out will use the funds to develop PhageMatch™, an AI powered platform that helps clinicians identify phages in partnership with University of Geneva (UNIGE) and University Hospital of Geneva (HUG). Antimicrobial resistance (AMR) is often described as the new cancer: left unchecked, it is projected to cause 10 million…
Read MoreTracy Laabs Appointed Director of the Wyss Center for Bio and Neuroengineering
The Wyss Center for Bio and Neuroengineering, one of the 17 academic institution partners of BioAlps since 2024, has announced a leadership transition. From 1st July 2026, Dr. Tracy Laabs will become the Center’s new Director, succeeding Prof. Dr. Erwin Böttinger, who is stepping down after more than three years at the helm. Since joining…
Read MoreEight Projects Selected for SMART Challenge 2026
Eight project leaders have been selected from 35 applications from French-speaking Switzerland, Ticino, France and even Lebanon. The goals of this first edition of the SMART Challenge, organised by SMART Confluence in Valais, are to get people moving in their daily lives and to transform existing spaces into places for physical activity. Here are the…
Read MoreBioscibex Wins BCV Prize and Ships its First Devices
Bioscibex, the Valais biotool startup born out of EPFL and based at the BioArk in Monthey, is having a banner few months. The company has both picked up a major regional accolade and reached a key commercial milestone by shipping its first bioreactor units to customers. On 11 June 2026 evening, Bioscibex took home the…
Read MoreCSEM and the EPFL spin-off ORYL Photonics win first prize at the 2026 EARTO Innovation Awards
On 10 June 2026, CSEM received the EARTO Innovation Award in the “Impact Expected” category for the development of a promising testing method for the evaluation of future medicines. This process, developed in collaboration with ORYL Photonics, is not only faster and less expensive, but also more sustainable than current techniques. New medicines must reach…
Read MoreCrìa Technologies Winners of a 2026 W.A. de Vigier Award
A Geneva-area startup has earned a place among Switzerland’s most prestigious recognitions for young entrepreneurs. Crìa Technologies SA, based in Plan-les-Ouates (GE) and led by CEO Giancarlo Mattiello, was named one of five winners of the 2026 W.A. de Vigier Award, each receiving CHF 120,000 in seed funding. The awards were presented on June 10…
Read MoreAtinary Selected as a 2026 Technology Pioneer by the World Economic Forum
Atinary, a pioneer in Self-Driving Labs® has been selected as a 2026 Technology Pioneer by the World Economic Forum. The Lausanne-based company joins an elite global group of leading technology start-ups recognized for their transformative potential and commitment to addressing major global challenges. Atinary is redefining the R&D paradigm by augmenting humans with AI and…
Read MoreHealthcare Week Luxembourg
Healthcare Week Luxembourg is a leading European event for professionals in healthcare, innovation and digital technology. The event is taking place on 30 September and 1 October 2026 at Luxexpo The Box in Luxembourg. Healthcare Week Luxembourg brings together the healthcare ecosystem to address the major challenges shaping the future of care: artificial intelligence, cybersecurity,…
Read MoreSymbios Finalist of The Swiss Medtech Award
The Swiss Medtech Award was presented on 10 June 2026 in Bern during the Swiss Medtech Day. Swiss Health Valley company Symbios Orthopédie SA was selected as a finalist. The Prize, worth CHF 50,000, went to Basel-based company Medartis. Positrigo AG, based in Zurich, was also in the final mix. Symbios Orthopédie SA is a family-run company…
Read More